The purpose of this study is to evaluate the oral bioavailability of the combination
Glimepiride/ extended release Metformin (GLI/METXR) (4/850mg) in healthy Mexican volunteers
in fasting conditions.
Methods: A prospective, longitudinal, open label, non randomized study, was performed, 24
volunteers were administrated with a single oral dose of GLI/METXR (4/850 mg).